Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Cal-Maine Foods Inc.’s (CALM - Snapshot Report) second-quarter 2013 earnings of 60 cents per share missed the Zacks Consensus Estimate of 99 cents. Earnings also deteriorated sharply from the year-ago level of 97 cents. The year-over-year decline in earnings was due to lower profit as a result of increased input costs.
Inside the Headline Numbers
Total revenue in the quarter under review grew 13.3% year over year to $328.9 million, surpassing the Zacks Consensus Estimate of $322.0 million. The upswing resulted from strong demand for eggs as well as higher average selling prices.
The largest U.S. producer and distributor of fresh-shell eggs stated that net average selling prices for shell eggs increased 4.0% year over year. Specialty eggs, which have higher and less cyclical selling prices, continued to see improved sales and accounted for 16.4% of total dozens sold. Around 22.9% of total shell egg sales revenue came from Specialty eggs in the quarter. Specialty egg prices were up 4.8% year over year.
Gross profit declined 16.6% from the prior-year quarter to $51.3 million, mainly due to the hike in feed cost. The drought in the Midwest growing region over the summer months has caused a spike in grain costs to a record level.
During the quarter, feed cost climbed 23.4% to nearly 57 cents per dozen on the back of higher corn and soybean prices.
Liquidity
Cal-Maine ended the quarter with cash and short-term investment of $163.1 million and long-term debt (less current maturities) of $29.3 million.
Our Take
Jackson, Mississippi-based Cal-Maine, which engages in production, grading, packaging, marketing and distribution of shell eggs, remains skeptic about the profitability environment in rest of fiscal 2013. We are also supportive of management’s cautious view.
The company has been struggling with input cost pressure for some time. Feed costs continued to hurt the company’s production costs. Management predicts feed costs to remain high and volatile for the rest of the fiscal year.
However, revenue growth momentum continued on strong retail demand. Further, demand for eggs at the retail level should surge during the fourth quarter owing to the holiday season. The company’s inorganic expansion also remains steady.
Cal-Maine Foods, along with its peer BRF - Brasil Foods S.A. (BRFS - Snapshot Report), currently carries a Zacks #3 Rank (short-term Hold rating).
Get the full Snapshot Report on CALM - FREE
Get the full Snapshot Report on BRFS - FREE